LLY Eli Lilly Options Ahead of EarningsAnalyzing the options chain and the chart patterns of LLY Eli Lilly prior to the earnings report this week,
I would consider purchasing the 450usd strike price Calls with
an expiration date of 2023-8-11,
for a premium of approximately $11.70.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
LLYC trade ideas
LDMR (Long Derivative Mean Reversion)(LDMR)Long Derivative Mean Reversion is primarily a tool for measuring risk and capital efficiency.
It's secondary functions include identify outliers in the assignment value of derivatives, maintaining a price target and producing trade placement recommendations.
This strategy has one simple input: the symbol of a correlated asset or index. It is recommended to use leveraged indexes in this input because they have a higher derivative correlation with those of round lots of the underlying.
When using this strategy you should always adjust the initial capital to what it will cost you to control 100 shares of the security.
If you intend to purchase shares then that value is 100x the close price.
if you intend to purchase call options to resell for premiums you use the initial premiums paid for the calculation.
If you intend to create a synthetic position you should add all deployed capital together, and that calculation will remain accurate until the max profit limit of your short option is reached.
Pyramiding is supported for trade placement. You should always review the historical depth and before placing the first trade ensure you have enough capital to cover the largest of those positions. Otherwise your results may be entirely incomparable to the risk and capital efficiency estimates the tool provides.
Let me know what you think. I am considering a private publishing and want to know what this is worth!
$LLY - SHORT SWING1. Playing the bearish divergence here.
2. Not seen here, but a rise in selling pressure (volume) was seen at the end of the trading day on Friday (4/28).
3. RVOL is slightly up, which is this case shows the bearish volume is higher than typical AKA above average.
4. Oscillator divergence starting to break down as price simultaneously makes newer highs.
Eli Lilly Finally Pulls BackDrug developer Eli Lilly shot to new highs earlier in the year, and now it’s finally pulled back.
The first pattern on today’s chart is the high-volume bullish candle on May 3. The move followed positive Phase 3 data for donanemab, its potential Alzheimer's disease treatment.
Second, prices are trying to hold the rising 21-day exponential moving average. That may indicate its short-term uptrend remains in effect.
Third, LLY apparently got ahead of itself last week and was unable to hold a new all-time high. But its quick pullback dragged stochastics to an oversold level where some buyers may feel more comfortable with the risk/reward.
TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more.
Important Information
TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means.
This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates.
Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
LLY - Sell the Good News??As compelling as the recent drug breakthrough may have been, it seems to have opened up an opportunity - time to short LLY stock?
Healthcare has shown a lot of strength in general this year, but has lately shown it can move independently of the market. For instance, during the August rally, it declined significantly. However, in this September slowdown, it has instead consolidated at nearly the same price level. You could view a short on this stock as a hedge to whatever you may be doing with the index.
LLY in general has been overvalued for a while, especially comparing to other healthcare stocks and even when accounting for future growth. However, a number of strong supports have formed as the stock has gone higher.
I think that a cautious short position would be good here, but pay close attention to the $320 and $300 level. It looks like it has rejected anything higher than the current levels (see bearish top wick & previous triple top.) There could be some news risk.
LLY - Rising Trend Channel [Mid Term]- LLY is in a rising trend channel in the medium long term.
- LLY has also received a positive signal from the moving average indicator, thus signaling a continued rise.
- LLY has broken up through resistance at 375.
- The short term momentum of the stock is strongly positive, with RSI above 70.
- Overall assessed as technically positive for the medium long term.
*EP: Enter Price, SL: Support, TP: Take Profit, CL: Cut Loss, TF: Time Frame, RST: Resistance, RTS: Resistance to be Support LT TP: Long Term Target Price
*Chart Pattern:
DT - Double Top | BEARISH | RED
DB - Double Bottom | BULLISH | GREEN
HNS - Head & Shoulder | BEARISH | RED
REC - Rectangle | BLUE
iHNS - inverse head & Shoulder | BULLISH | GREEN
Verify it first and believe later.
WavePoint ❤️
LLY - How to handle earningsNYSE:LLY reports this Thursday. The drop in early March to test the bottom of the uptrend was a great opportunity. Now it's at all time high, showing bearish divergence, and has a history of price reversals after earnings releases.
I'll be looking for updates on their pipeline management, monjaro production and growth, and progress toward Alzheimer treatment. The latter is high potential, but clinical trials in that space fail regularly.
I'll likely take a little profit before earnings and then re-accumulate to pullbacks to the HKEX:347 -356 range.
OVERBOUGHTRSI is at 82.17. THIS IS NOT TO LONG ENTRY LEVEL. (EL)
It is often important to Wait for EL especially when price is struggling.
Price is trying to touch the top of the cup.
There is not a well formed handle but I drew a green line where I see some support. You may see this differently.
ATH is 384.44.
Spinning top representing indecision at resistance.
No recommendation
Price is above the .236 of the trend up.
Overbought refers to a security with a price that's higher than its intrinsic value. Many investors use price-earnings (P/E) ratios to determine if a stock is overbought, while traders use technical indicators, like the relative strength index (RSI).
An oversold market is one that has fallen sharply and is expected to bounce higher. On the other hand, an overbought market has risen sharply and is possibly ripe for a decline. Securities can remain overbought or oversold for extended periods of time.